Neurocrine Biosciences Inc. Message Board

Given we will also get some secondary results on its impact on schizo could get a nice bounce if data is all positive from these two P2b trials. Any bounce north of $15/$16 would be very nice.

frogs

"Dito" your comments on what management has controll over.

But if what pizza stated in his original post is proven to be reality:

Second half 2014 is not first half 2014 and to simple state 2014 for top line to me is say'n management is not fourth coming with the real facts. Those clowns must think investors are stupid an so the results will be the stock will sell off

frogs

Sentiment: Hold

Detail Endo Violet Petal slide is not in this new corp presentation.

Analyst will be asking Question on the Q1 CC on Thursday so I hope they read these posts get some facts in front of them and ask some serious time line questions.

I'm a buyer of some traders if we get a pull back under $11 as VMAT2 will be a significant stock price driver this summer. My core position is big enough

frogs

Kinect2 study is for schizo patients

frogs

August is when the second VMAT2 trial should read out top line results. this is the trial that enrolled only schizo patients ........... if we see the drug have an effect via a secondary endpoint VMAT could have the potential of being a pipeline within a pipeline with multi $$billion potential ................ this is my pump for the day .... LOL

frogs

Sentiment: Strong Buy

Another new 52H today and more to come

this is a stock with very few retail investors holding shares so its going to be some what volitile which IMO means lower lows and Higher highs as we get VMAT2 data over the summer.

If VMAT shows a positive secondary end point in schizo in August P2 read out.
The stock will go into the low $20's.

No matter what happens this summer I will be hedging my long position with out of the money put options for Elagolix P3 Endo results. No SPA so the p3 results could get called into question by some rogue analyst. We all know how the game is played.

Even with the shares outstanding doubling since the Indiplon crash we could see a $40 share price by mid 2014. if all goes well.

frogs

Sentiment: Strong Buy

Hey short stuff

post your heart out

NBIX is still going higher over the next 6 months

New intra day High $12.44

Nice POP last Thursday, this stock is heading for $16/$18 on positive VMAT2 p2 studies this summer.

Breaking $12 with brisk volume bodes well for setting up a $10 floor for NBIX on any general market pull back.

frogs